Literature DB >> 24402480

Advances and surgical considerations in the treatment of moyamoya disease.

Eric J Arias1, Colin P Derdeyn, Ralph G Dacey, Gregory J Zipfel.   

Abstract

Moyamoya is a rare disorder that involves steno-occlusive arterial changes of the anterior circulation, along with proliferative development of basal arterial collaterals. It is either idiopathic (called moyamoya disease) or the result of a specific underlying condition such as atherosclerosis, radiation therapy, or sickle cell disease (called moyamoya syndrome or phenomenon). In recent years, numerous insights into and advances in the understanding, evaluation, and management of moyamoya patients have occurred. This article briefly reviews the spectrum of moyamoya conditions and then provides a synopsis of numerous recent investigations that shed light on various aspects of the disease, including its clinical characteristics, natural history, underlying pathology, imaging, surgical techniques, and long-term patient outcome.

Entities:  

Mesh:

Year:  2014        PMID: 24402480     DOI: 10.1227/NEU.0000000000000229

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  17 in total

1.  Treatment course and outcomes after revascularization surgery for moyamoya disease in adults.

Authors:  Amanda Kahn; Gurmeen Kaur; Laura Stein; Stanley Tuhrim; Mandip S Dhamoon
Journal:  J Neurol       Date:  2018-09-08       Impact factor: 4.849

2.  Treatment of Progressive Herpes Zoster-Induced Vasculopathy with Surgical Revascularization: Effects on Cerebral Hemodynamics.

Authors:  Sarah K Lants; Jennifer M Watchmaker; Meher R Juttukonda; Larry T Davis; Manus J Donahue; Matthew R Fusco
Journal:  World Neurosurg       Date:  2017-12-20       Impact factor: 2.104

3.  Hemodynamic mechanisms underlying elevated oxygen extraction fraction (OEF) in moyamoya and sickle cell anemia patients.

Authors:  Jennifer M Watchmaker; Meher R Juttukonda; Larry T Davis; Allison O Scott; Carlos C Faraco; Melissa C Gindville; Lori C Jordan; Petrice M Cogswell; Angela L Jefferson; Howard S Kirshner; Manus J Donahue
Journal:  J Cereb Blood Flow Metab       Date:  2016-12-28       Impact factor: 6.200

4.  Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with moyamoya disease: A retrospective study of 76 procedures.

Authors:  Jinbing Zhao; Hongyi Liu; Yuanjie Zou; Wenbin Zhang; Shengxue He
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

5.  Endothelial Progenitor Cells Induce Angiogenesis: a Potential Mechanism Underlying Neovascularization in Encephaloduroarteriosynangiosis.

Authors:  Qian-Nan Wang; Zheng-Xing Zou; Xiao-Peng Wang; Qian Zhang; Ya-Qun Zhao; Lian Duan; Xiang-Yang Bao
Journal:  Transl Stroke Res       Date:  2020-07-06       Impact factor: 6.829

6.  A Prospective, Longitudinal Magnetic Resonance Imaging Evaluation of Cerebrovascular Reactivity and Infarct Development in Patients With Intracranial Stenosis.

Authors:  Meher R Juttukonda; Larry T Davis; Sarah K Lants; Spencer L Waddle; Chelsea A Lee; Niral J Patel; Lori C Jordan; Manus J Donahue
Journal:  J Magn Reson Imaging       Date:  2021-03-24       Impact factor: 5.119

7.  The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids.

Authors:  Weiping Xiao; Jiabin Su; Xinjie Gao; Heng Yang; Ruiyuan Weng; Wei Ni; Yuxiang Gu
Journal:  Microbiome       Date:  2022-04-17       Impact factor: 14.650

8.  Vaso-Occlusive Pain Management in a Patient With Sickle Cell Disease Associated With Moyamoya Syndrome.

Authors:  Drezelle Mills; Annie Wang; Iya Dubson
Journal:  Cureus       Date:  2022-03-30

Review 9.  [Advances in surgical treatment of ischemic cerebrovascular disease].

Authors:  Jianmin Zhang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-05-25

10.  Current trends in pediatric moyamoya: a survey of international practitioners.

Authors:  Harishchandra Lalgudi Srinivasan; Moran Hausman-Kedem; Edward R Smith; Shlomi Constantini; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2021-03-10       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.